Microscopic polyangiitis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

The early case reports of microscopic polyangiitis provide a historical context and foundation for better understanding of the current concepts of these diseases microscopic polyangiitis. Microscopic polyangiitis was first introduced by Dr. Friedrich Wohlwill, a German neuropathologist, who described two patients with transmural periarteritis with glomerulonephritis in 1923. Historically, most forms of vasculitis like microscopic polyangiitis described subsequently classified on the basis of features similar to or distinct from polyarteritis.

Historical Perspective

Discovery

Microscopic polyangiitis was first discovered by Dr. Friedrich Wohlwill, a German neuropathologist, in 1923 following patients with transmural periarteritis with glomerulonephritis.^[1]^[2]^[3]
Systemic vasculitis first complete description was given by Kussmaul and Maier in 1866.
Microscopic polyarteritis was the term given by Wainwright and Davson to describe this phenotype in 1950.^[4]

Landmark Events in the Development of Treatment Strategies

Rituximab plays an important role in the newly developed strategies in treating microscopic polyangiitis.^[5]

References

↑ Wohlwill, F. (1923). “Über die nur mikroskopisch erkennbare Form der Periarteriitis nodosa”. Virchows Arch. path Anat. 246 (1): 377–411. doi:doi:10.1007/BF01947911 Check |doi= value (help).
↑ Matteson EL (2002). “Historical perspective of vasculitis: polyarteritis nodosa and microscopic polyangiitis”. Curr Rheumatol Rep. 4 (1): 67–74. PMID 11798985.
↑ Langford CA (May 2011). “Cyclophosphamide as induction therapy for Wegener’s granulomatosis and microscopic polyangiitis”. Clin. Exp. Immunol. 164 Suppl 1: 31–4. doi:10.1111/j.1365-2249.2011.04364.x. PMC 3095863. PMID 21447129.
↑ Chung SA, Seo P (August 2010). “Microscopic polyangiitis”. Rheum. Dis. Clin. North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
↑ Jayne D (January 2008). “Challenges in the management of microscopic polyangiitis: past, present and future”. Curr Opin Rheumatol. 20 (1): 3–9. doi:10.1097/BOR.0b013e3282f370d1. PMID 18281850.

Template:WH Template:WS

[doi:10.1007/BF01947911-1] Wohlwill, F. (1923). “Über die nur mikroskopisch erkennbare Form der Periarteriitis nodosa”. Virchows Arch. path Anat. 246 (1): 377–411. doi:doi:10.1007/BF01947911 Check |doi= value (help).

[pmid11798985-2] Matteson EL (2002). “Historical perspective of vasculitis: polyarteritis nodosa and microscopic polyangiitis”. Curr Rheumatol Rep. 4 (1): 67–74. PMID 11798985.

[pmid21447129-3] Langford CA (May 2011). “Cyclophosphamide as induction therapy for Wegener’s granulomatosis and microscopic polyangiitis”. Clin. Exp. Immunol. 164 Suppl 1: 31–4. doi:10.1111/j.1365-2249.2011.04364.x. PMC 3095863. PMID 21447129.

[pmid20688249-4] Chung SA, Seo P (August 2010). “Microscopic polyangiitis”. Rheum. Dis. Clin. North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.

[pmid18281850-5] Jayne D (January 2008). “Challenges in the management of microscopic polyangiitis: past, present and future”. Curr Opin Rheumatol. 20 (1): 3–9. doi:10.1097/BOR.0b013e3282f370d1. PMID 18281850.

[1]

[2]

[3]

[4]

[5]